SB 2549
Pub
Opioids - As enacted, adds that a healthcare provider who subcontracts through the contracted healthcare vendor with the department of correction may prescribe a buprenorphine product for the treatment of opioid use disorder if other certain listed criteria are met. - Amends TCA Title 53 and Title 63.
- Tennessee
- Senate
- Introduced Feb 2, 2026
- Session 114
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Tennessee’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
21 actions-
Pub. Ch. 677
-
Effective date(s) 04/07/2026
-
Signed by Governor.
-
Transmitted to Governor for action.
-
Signed by H. Speaker
-
Signed by Senate Speaker
-
Enrolled and ready for signatures
-
Subst. for comp. HB.
-
Passed H., Ayes 82, Nays 0, PNV 2
-
Rcvd. from S., held on H. desk.
-
Passed Senate, Ayes 30, Nays 1
-
Engrossed; ready for transmission to House
-
Sponsor(s) Added.
-
Placed on Senate Regular Calendar for 3/16/2026
-
Recommended for passage, refer to Senate Calendar Committee
-
Action deferred in Senate Health and Welfare Committee to 3/4/2026
-
Placed on Senate Health and Welfare Committee calendar for 3/4/2026
-
Placed on Senate Health and Welfare Committee calendar for 2/25/2026
-
Passed on Second Consideration, refer to Senate Health and Welfare Committee
-
Filed for introduction
-
Introduced, Passed on First Consideration